🔥🐔 BizChicken 🐔🔥
Companies Similar to Organovo Holdings, Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Bio-Path Holdings, Inc.
DNAbilize
Bio-Path Holdings, Inc. is a clinical and preclinical stage oncology focused RNAi nano particle drug development company, developing products based on the DNAbilize technology. The company is advancing its lead drug candidate, prexigebersen, for the treatment of AML and myelodysplastic syndrome.
Symbol: BPTH
Recent Price: $1.17
Industry: Biotechnology
CEO: Mr. Peter H. Nielsen MBA
Sector: Healthcare
Employees: 10
Address: 4710 Bellaire Boulevard, Bellaire, TX 77401
Phone: 832 742 1357
Leadership
- Peter Nielsen, Chief Executive Officer, Chief Financial Officer
- Ana Tari Ashizawa, PhD, MBA, Senior Vice President of Research, Development & Clinical Design
- Anthony Price, MBA, Senior Vice President of Finance, Accounting & Administration
- Michael Hickey, MBA, Vice President of Clinical Operations
- Michael Roberts, Director of Manufacturing Planning & Engineering
- Chairman of the Board,
- President,
- Heath Cleaver, Director
- Paul Aubert, Director
- Douglas P. Morris, Director
- Aline Sherwood, Director
Last updated: 2024-12-31
Novavax, Inc.
NVX-Co V2373
Novavax, Inc. is a biotechnology company focused on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases. Their vaccine candidates include NVX-Co V2373, Nano Flu, and Res Vax. The company operates collaboratively with Takeda Pharmaceutical Company Limited on COVID-19 vaccine development.
Contact | Careers | Careers | Careers | Careers | About | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | About | About | About | About | About | About
Symbol: NVAX
Recent Price: $7.93
Industry: Biotechnology
CEO: Mr. John Charles Jacobs M.B.A.
Sector: Healthcare
Employees: 1543
Address: 21 Firstfield Road, Gaithersburg, MD 20878
Phone: 240 268 2000
Last updated: 2024-12-31
bluebird bio, Inc.
betibeglogene autotemcel, lovotibeglogene autotemcel, elivaldogene autotemcel
bluebird bio, Inc. is a biotechnology company that researches, develops, and commercializes transformative gene therapies for severe genetic diseases, including treatments for ß-thalassemia, sickle cell disease, and cerebral adrenoleukodystrophy.
About | Leadership | DEI | About | About | About | Contact | Careers | About | About | About | About
Symbol: BLUE
Recent Price: $7.86
Industry: Biotechnology
CEO: Mr. Andrew Obenshain
Sector: Healthcare
Employees: 375
Address: 60 Binney Street, Cambridge, MA 02142
Phone: 339 499 9300
Leadership
- Sarah Alspach, Senior Vice President, External Affairs
- Rich Colvin, MD, PhD, Chief Medical Officer
- Kasra Kasraian, Senior Vice President, Technical Development and Operations
- Tom Klima, Chief Commercial & Operating Officer
- Andrew Obenshain, Chief Executive Officer
- Scott Shoemaker, Senior Vice President, Quality
- James Sterling, Chief Financial Officer
- Joe Vittiglio, Chief Business and Legal Officer
- Andrea Walton, Chief People Officer
- Leslie Wilder, Vice President, Head of Regulatory Science
- Mark Vachon, Chairman; Formerly of GE
- John O. Agwunobi, M.D., Formerly of Herbalife Nutrition
- Mike Cloonan, President and Chief Executive Officer, Sionna Therapeutics
- Charlotte Jones-Burton, M.D., Formerly of Chinook Therapeutics
- Lis Leiderman, M.D., CHIEF FINANCIAL OFFICER & CORPORATE DEVELOPMENT OFFICER AT DEWPOINT THERAPEUTICS
- Nick Leschly, Former Chief Kairos Officer, 2seventy Bio
- Richard Paulson, President and Chief Executive Officer at Karyopharm Therapeutics Inc.
- Najoh Tita-Reid, Chief Brand and Experience Officer, Mars Petcare
Last updated: 2024-12-31
Biomerica, Inc.
diagnostic and therapeutic products
Biomerica, Inc. is a biomedical technology company that develops, patents, manufactures, and markets diagnostic and therapeutic products for medical conditions and diseases worldwide, focusing on gastrointestinal diseases, food intolerances, and diabetes.
About | About | Contact | Contact | About | News | News | About | About | About | About | About
Symbol: BMRA
Recent Price: $0.31
Industry: Medical - Devices
CEO: Mr. Zackary S. Irani
Sector: Healthcare
Employees: 64
Address: 17571 Von Karman Avenue, Irvine, CA 92614
Phone: 949 645 2111
Last updated: 2024-12-31
Bioventus Inc.
Pain Treatments, Surgical Solutions, Restorative Therapies
Bioventus Inc. is a medical device company that develops and commercializes treatments designed to engage and enhance the body's natural healing process, offering products like pain treatments, surgical solutions, and restorative therapies.
About | Leadership | About | About | About | About | About | Contact | Careers | Careers | Careers | Careers | Careers | About | About | About | About | About
Symbol: BVS
Recent Price: $10.54
Industry: Medical - Devices
CEO: Mr. Robert E. Claypoole
Sector: Healthcare
Employees: 1030
Address: 4721 Emperor Boulevard, Durham, NC 27703
Phone: 919 474 6700
Leadership
- Robert Claypoole, Chief Executive Officer
- Mark Singleton, Senior Vice President and Chief Financial Officer
- Katrina Church, Chief Compliance Officer
- Anthony D’Adamio, Senior Vice President and General Counsel
- Helen Leupold, Senior Vice President, Chief Human Resources Officer
- Anthony Doyle, General Manager, Pain Treatment & Restorative Therapies
- Kellie Stefaniak, Vice President of Global Regulatory and Quality
- Mike Crowe, Senior Vice President, Operations
- Andrew Hosmer, General Manager, Surgical Solutions
- David Rennie, General Manager, International
Last updated: 2024-12-31
Humacyte, Inc.
Human Acellular Vessels (HAVs)
Humacyte, Inc. develops and manufactures off-the-shelf, implantable, and bioengineered human tissues for various therapeutic areas, focusing on human acellular vessels (HAVs) for vascular repair and other medical needs.
Symbol: HUMA
Recent Price: $5.09
Industry: Biotechnology
CEO: Dr. Laura E. Niklason M.D., Ph.D.
Sector: Healthcare
Employees: 183
Address: 2525 East North Carolina Highway 54, Durham, NC 27713
Phone: 919 313 9633
Last updated: 2024-12-31
INVO Bioscience, Inc.
INVOcell
INVO Bioscience, Inc. is a fertility company providing assisted reproductive technology solutions with its flagship product, INVOcell, promoting in vivo fertilization and early embryo development. The company aims to make fertility care more accessible worldwide.
Symbol: INVO
Recent Price: $0.83
Industry: Medical - Devices
CEO: Mr. Steven M. Shum
Sector: Healthcare
Employees: 25
Address: 5582 Broadcast Court, Sarasota, FL 34240
Phone: 978 878 9505
Last updated: 2024-12-31
MediciNova, Inc.
MN-166 (ibudilast)
Medici Nova, Inc. is a biopharmaceutical company focused on developing novel therapeutics for serious diseases with unmet medical needs, including neurologic disorders, fibrotic diseases, and solid tumor cancers.
Symbol: MNOV
Recent Price: $2.11
Industry: Biotechnology
CEO: Dr. Yuichi Iwaki M.D., Ph.D.
Sector: Healthcare
Employees: 13
Address: 4275 Executive Square, La Jolla, CA 92037
Phone: 858 373 1500
Leadership
- Yuichi Iwaki, M.D., Ph.D., President and Chief Executive Officer, and Founder
- Kazuko Matsuda, M.D., Ph.D, MPH, Chief Medical Officer
- David H. Crean, Ph.D., Chief Business Officer
- Jason J. Kruger, CPA (inactive), Chief Financial Officer
- Hideki Nagao, Member of the Board of Directors
- Carolyn Beaver, Member of the Board of Directors
- Nicole Lemerond, CFA, Member of the Board of Directors
Last updated: 2024-12-31
NeuroBo Pharmaceuticals, Inc.
ANA001
A clinical-stage biotechnology company developing therapies for neurodegenerative, infectious, and cardiometabolic diseases.
Symbol: NRBO
Recent Price: $2.36
Industry: Biotechnology
CEO: Mr. Hyung-Heon Kim
Sector: Healthcare
Employees: 8
Address: 200 Berkeley Street, Boston, MA 02116
Phone: 857 702 9600
Last updated: 2024-12-31
Novo Integrated Sciences, Inc.
multidisciplinary primary health care related products and services
Novo Integrated Sciences, Inc., along with its subsidiaries, provides multidisciplinary primary healthcare products and services, operating through healthcare services and product manufacturing segments.
ESG | About | Vision/Values | Leadership | About | Contact | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | About | About | About | About | About
Symbol: NVOS
Recent Price: $0.05
Industry: Medical - Care Facilities
CEO: Mr. Robert Mattacchione
Sector: Healthcare
Employees: 127
Address: 11120 NE 2nd Street, Bellevue, WA 98004
Phone: 206 617 9797
Leadership
- Robert Mattacchione, CEO, Novo Integrated Sciences
- Chris David, COO, Novo Integrated Sciences
- Robert Oliva, President, Novo Integrated Sciences
- Dr Joseph M. Chalil, Chief Medical Officer (CMO), Chairman, Medical Advisory Board
- Vivek Sethi, NVOS Principal Financial Officer (PFO)
- James Asher, President
- Christopher Wade, NHL EVP, Strategy & Operations
Last updated: 2024-12-31
Organovo Holdings, Inc.
Novo Gen Bioprinters
Organovo Holdings, Inc. is a biotechnology company that develops 3D tissues to model human diseases, utilizing proprietary bioprinting technologies such as Novo Gen Bioprinters for fabricating living tissues.
About | About | About | About | Leadership | Directors | Contact | Contact | Contact | Careers
Symbol: ONVO
Recent Price: $0.36
Industry: Biotechnology
CEO: Mr. Keith E. Murphy
Sector: Healthcare
Employees: 20
Address: 11555 Sorrento Valley Road, Solana Beach, CA 92121
Phone: 858 224 1000
Leadership
- Keith Murphy, Executive Chairman, CEO
- Thomas P. Hess, Chief Financial Officer
- Curtis Tyree, Ph.D., Senior Vice President, Strategy and Business Development
- Adam K. Stern, CEO
- Alison Milhous, Vice President, Accounting
- David Gobel, CEO
- Doug Cohen, President and Chief Executive Officer
- Vaidehi Joshi, Director of Discovery Biology
Last updated: 2024-12-31
Organogenesis Holdings Inc.
Advanced Wound Care and Surgical Products
Organogenesis Holdings Inc. develops, manufactures, and commercializes regenerative medicine solutions for advanced wound care, surgical, and sports medicine markets in the United States.
Symbol: ORGO
Recent Price: $3.16
Industry: Drug Manufacturers - Specialty & Generic
CEO: Mr. Gary S. Gillheeney Sr.
Sector: Healthcare
Employees: 862
Address: 85 Dan Road, Canton, MA 02021
Phone: 781 575 0775
Last updated: 2024-12-31
Ovid Therapeutics Inc.
OV101, OV329, OV350, OV882, OV815
Ovid Therapeutics Inc., a biopharmaceutical company based in New York, is dedicated to developing impactful medicines for neurological disorders. They have a range of drug candidates like OV101 and are involved in various clinical trials.
Our Story | Leadership | Directors | About | Our Story | Contact | About | About | About | About | About | Culture | Culture | Vision/Values | Culture | About | Culture | Culture | About | Jobs | Careers | Careers | Jobs | About | About | About | Careers | Vision/Values | About | About | About | About | About | About
Symbol: OVID
Recent Price: $0.96
Industry: Biotechnology
CEO: Dr. Jeremy Max Levin Ba Zoology, Dphil, M.D., Mb Bchir, Ph.D.
Sector: Healthcare
Employees: 40
Address: 1460 Broadway, New York, NY 10036
Phone: 646 661 7661
Leadership
- Jeremy M. Levin, D.Phil, MB BChir, Chief Executive Officer and Chairman
- Meg Alexander, President and Chief Operating Officer
- Zhong Zhong, Ph.D., Chief Scientific Officer
- Jeffrey Rona, Chief Business and Financial Officer
- Amanda Banks, M.D., Chief Development Officer
- Julia Tsai, Ph.D., Senior Vice President of Clinical Development
- Karen Bernstein, Ph.D., Director, Chair of the Compensation Committee, Member of the Audit and Nominating and Corporate Governance Committees
- Barbara G. Duncan, MBA, Director, Chair of the Audit Committee, Member of the Nominating and Corporate Governance Committee
- Bart Friedman, J.D., Lead Independent Director, Chair of the Nominating and Corporate Governance Committee, Member of the Audit and Compensation Committees
- Michael Poole, M.D., FACP, Director, Member of the Audit and Compensation Committees
- Kevin Fitzgerald, Ph.D., Director, Member of the Nominating and Corporate Governance Committee
Last updated: 2024-12-31
Sonnet BioTherapeutics Holdings, Inc.
SON-1010, SON-080
Sonnet Bio Therapeutics Holdings, Inc. is a clinical stage oncology-focused biotechnology company developing biologic medicines using its human albumin binding technology. The company is based in Princeton, New Jersey, and has lead candidates such as SON-1010 for non-small cell lung cancer, and SON-080 for neuropathies.
Symbol: SONN
Recent Price: $1.48
Industry: Biotechnology
CEO: Dr. Pankaj Mohan Ph.D.
Sector: Healthcare
Employees: 12
Address: 100 Overlook Center, Princeton, NJ 08540
Phone: 609-375-2227
Leadership
- Pankaj Mohan, Ph.D., Founder, CEO & Chairman
- Jay Cross, Chief Financial Officer
- John K. Cini, Ph.D., Chief Scientific Officer & Co-Founder
- Susan Dexter, Chief Technical Officer
- Richard Kenney, M.D., Chief Medical Officer
- Albert Dyrness, Board Member
- Nailesh Bhatt, Chief Executive Officer & Board Member
- Raghu Rao, Board Member
- Donald Griffith, Financial Controller
- Lori McNeill, Board Member
Last updated: 2024-12-31
Tevogen Bio Holdings Inc.
TVGN 489
Tevogen Bio Holdings Inc. is a clinical-stage biotechnology company developing off-the-shelf precision T cell therapeutics focusing on virology, oncology, and neurology, with a key focus on COVID-19 and long COVID treatments.
About | News | News | News | About | News | News | Contact | About | About | Careers | About | About | About | About | About | About | About
Symbol: TVGN
Recent Price: $1.05
Industry: Biotechnology
CEO: Dr. Ryan H. Saadi M.D., M.P.H, M.P.H.
Sector: Healthcare
Employees: 17
Address: 15 Independence Blvd, Warren, NJ 07059
Phone: 877 838 6436
Last updated: 2024-12-31
Vir Biotechnology, Inc.
Sotrovimab (VIR-7832), VIR-2218, VIR-3434, VIR-2482, VIR-1111
Vir Biotechnology, Inc. is a commercial-stage immunology company developing therapeutic products to treat and prevent serious infectious diseases, including COVID-19, hepatitis B, influenza A, and HIV.
Vision/Values | About | Leadership | About | Contact | Contact | Careers | Jobs | About | About
Symbol: VIR
Recent Price: $7.33
Industry: Biotechnology
CEO: Dr. Marianne De Backer M.B.A., M.Sc., Ph.D.
Sector: Healthcare
Employees: 587
Address: 499 Illinois Street, San Francisco, CA 94158
Phone: 415 906 4324
Leadership
- Marianne De Backer, M.Sc., Ph.D., MBA, Chief Executive Officer and Director
- Jeff Calcagno, M.D., Executive Vice President and Chief Business Officer
- Vanina de Verneuil, J.D., Executive Vice President, General Counsel and Corporate Secretary
- Mika Kakefuda Derynck, M.D., Executive Vice President, Therapeutic Area Head Oncology
- Mark Eisner, M.D., M.P.H., Executive Vice President and Chief Medical Officer
- Jenny Gumm, Ed.D., MBA, Executive Vice President, Chief Human Resources Officer
- Aine Hanly, Ph.D., Executive Vice President and Chief Technology Officer
- Jason O’Byrne, MBA, Executive Vice President and Chief Financial Officer
- Jennifer Eileen Towne, Ph.D., Executive Vice President and Chief Scientific Officer
- Arran Attridge, Senior Vice President Corporate Communications
- Antonio Lanzavecchia, M.D., Senior Vice President and Senior Research Fellow
- Amalio Telenti, M.D, Ph.D., Executive Vice President and Senior Research Fellow
Last updated: 2024-12-31
Vor Biopharma Inc.
VOR33
Vor Biopharma, Inc. is a clinical-stage company focused on developing engineered hematopoietic stem cell (e HSC) therapies for cancer patients, with a leading product, VOR33, in phase 1/2 trials for AML and other hematological malignancies.
About | Vision/Values | About | Leadership | Directors | About | About | Contact | Contact | News | Careers | About | About | About
Symbol: VOR
Recent Price: $1.19
Industry: Biotechnology
CEO: Dr. Robert Ang M.B.A., M.D., MBBS
Sector: Healthcare
Employees: 168
Address: 100 Cambridgepark Drive, Cambridge, MA 02140
Phone: 617 655 6580
Leadership
- Robert Ang, MBBS, MBA, President and Chief Executive Officer
- Eyal Attar, MD, Chief Medical Officer
- Tirtha Chakraborty, PhD, Chief Scientific Officer
- Han Choi, MD, LLM, Chief Financial Officer
- John King, MBA, Chief Commercial Officer and Head of Business Development
- Tania Philipp, Chief People Officer
- David Phillips, MBA, Senior Vice President, Head of Quality
- Samir Vattompadam, MS, Senior Vice President, Portfolio Strategy and Program Management
- Daniella Beckman, Board of Directors
- David Lubner, Board of Directors
- Bill Lundberg, MD, Board of Directors
- Fouad Namouni, MD, Board Of Directors
- Matthew R. Patterson, Chairman, Board of Directors
- Josh Resnick, MD, Board of Directors
Last updated: 2024-12-31
Ginkgo Bioworks Holdings, Inc.
platform for cell programming
Ginkgo Bioworks Holdings, Inc. develops a platform used to program cells for biological production of products such as therapeutics, food ingredients, and chemicals. It serves markets in specialty chemicals, agriculture, food, consumer products, and pharmaceuticals.
About | About | Contact | Contact | About | About | About | About | Vision/Values | About | About | About | Culture | About | Careers | About | About | About
Symbol: DNA
Recent Price: $9.44
Industry: Biotechnology
CEO: Dr. Jason Kelly
Sector: Healthcare
Employees: 1218
Address: 27 Drydock Avenue, Boston, MA 02210
Phone: 877 422 5362
Last updated: 2024-12-31
Creative Medical Technology Holdings, Inc.
Imm Celz
Creative Medical Technology Holdings, Inc. is a biotechnology company focusing on using adult stem cell treatments for immunology, urology, orthopedics, and neurology, offering solutions like Caver Stem, Fem Celz, Stem Spine, Imm Celz, and Ova Stem.
Symbol: CELZ
Recent Price: $2.34
Industry: Biotechnology
CEO: Mr. Timothy Warbington
Sector: Healthcare
Employees: 4
Address: 211 East Osborn Road, Phoenix, AZ 85012
Phone: 480 399 2822
Last updated: 2024-12-31
BioLife Solutions, Inc.
bioproduction tools and services
Bio Life Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services essential for the cell and gene therapy industry globally. The company's offerings include biopreservation media products, automated thawing products, cloud-connected shipping containers, and storage solutions for biologics and pharmaceuticals.
About | Events | Leadership | Leadership | Management | About | About | News | Contact | Contact | Contact | Contact | Contact | About | About | About | About | About
Symbol: BLFS
Recent Price: $26.27
Industry: Medical - Instruments & Supplies
CEO: Mr. Roderick de Greef
Sector: Healthcare
Employees: 409
Address: 3303 Monte Villa Parkway, Bothell, WA 98021
Phone: 425 402 1400
Leadership
- Rod de Greef, Chairman & Chief Executive Officer
- Aby J. Mathew, Ph.D., Executive Vice President and Chief Scientific Officer
- Karen Foster, Chief Quality and Operations Officer
- Troy Wichterman, Chief Financial Officer
- Todd Berard, Chief Marketing Officer
- Garrie Richardson, Chief Revenue Officer
- Sarah Aebersold, Chief Human Resources Officer
- Mike Pallotta, Global VP, Hardware and Electrical Engineering
- Brett Stucker, VP of Cybersecurity and Information Security Officer
- Amy DuRoss,
- Rachel Ellingson,
- Joydeep Goswami, MBA, Ph.D.,
- Tim Moore,
- Joseph Schick, Chairman – Audit Committee
- Andrew Hinson,
- Anthony Davies, Ph.D.,
- Colleen Delaney, M.D., M.Sc.,
- Dayong Gao, Ph.D.,
- Erik Woods, Ph.D., HCLD(ABB),
- Jon Rowley, Ph.D.,
- John McMannis, Ph.D.,
- Jerry E. Cooley, M.D.,
- Jason Acker, MBA, Ph.D.,
- Lizabeth Cardwell, MT (ASCP), MBA, RAC,
- Scott R. Burger, M.D.,
- Shelly Heimfeld, Ph.D.,
Last updated: 2024-12-31